The abstract is read at the publisher; the summary is JClub's.
AI-driven toxicogenomics models using support vector machines, random forests, and deep learning architectures improve predictive accuracy and sensitivity for early toxicity prediction in environmental and pharmaceutical safety contexts.
- Why it matters: Multi-omics data from transcriptomics, proteomics, and metabolomics are increasingly complex, and conventional toxicology struggles to extract predictive molecular signals early enough for risk assessment.
- What they did: The paper reviews ML-based, data-driven approaches that integrate multi-omics to identify toxicity-associated biomarkers, elucidate mechanisms of action, and predict adverse drug and environmental effects prior to clinical manifestation.
- The result: AI-driven models are reported to improve prediction accuracy, sensitivity, and scalability versus traditional toxicological approaches, enabling earlier decision-making and reduced reliance on animal testing while raising issues like heterogeneity and interpretability.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.